Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 11 Aug 2026 for KLAVIYO, INC, €247k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Summit Investors GE IX-VC IV, LLC: trading record in brief
Summit Investors GE IX-VC IV, LLC has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Klaviyo, Inc. and LifeStance Health Group, Inc. We count 2 filings; the first trade dates from 10 August 2026 and the latest from 11 August 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 11 August 2026: a transaction of €247k, in Klaviyo, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Summit Investors GE IX-VC IV, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
15,531 shares@ US$18.36Series A Common stock, par value $0.001 per shareSEC144:0001654074-26-000005
12,165 shares@ US$10.620.0031% mcap100.0% of flowCommon StockSEC144:0001654074-26-000003
2 of 2 declarations
